2024 annual financial data
Eikon Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -260,343,000 USD and net income was -243,814,000 USD.
Operating cash flow was -134,799,000 USD.
Get free Eikon Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -260,343,000 USD
- Net income
- -243,814,000 USD
- Operating cash flow
- -134,799,000 USD